The American Kidney Fund’s Ambassadors make up our Advocacy Network, and the team plays an important role in our efforts to raise awareness of kidney disease and ensure that every kidney patient has access to quality health care.
We advocate on behalf of more than 700,000 Americans living with kidney failure, 37 million Americans with chronic kidney disease (CKD), and the millions more who are at risk. Our Ambassadors perform a vital role by influencing legislators and thought leaders so that public policy aims to improve the lives of kidney patients. Our Ambassadors also educate communities about kidney disease, its causes, and how to prevent it. Your voice is powerful!
Congressional Briefing on Stark Health Disparities in COVID-19 PandemicThe American Kidney Fund held a Congressional briefing to focus on factors that have contributed to the disproportionate impact of COVID-19 on communities of color. The briefing—COVID-19, Health Disparities and the Social Determinants of Health—took place September 16 via Zoom. The briefing can be viewed below.
- Advocate for kidney patients
- Take action on current issues
- The American Kidney Fund’s Digital Advocacy Day
- Become an AKF Ambassador
- Charitable premium assistance
- Public policy and kidney disease
- Advocacy blog
- Get the latest news
- Thank you to our corporate sponsors who support our year-round advocacy efforts:
Advocate for kidney patients
Our Advocacy Network plays a vital role in influencing public policy that helps ensure access to quality care for kidney patients, as well as educating communities about kidney disease, its causes, and how to prevent it. Learn more about advocacy and how you can make your voice heard.
Take action on current issues
Keeping policymakers informed is critical in the fight against kidney disease. Add your voice to thousands of other voices in our Advocacy Network and help us make a difference!
The American Kidney Fund’s Digital Advocacy Day
Ambassadors all over the country joined in advocating for legislation to address the health disparities that often lead people to develop kidney disease, ensuring that at-risk patients have access to the health care and healthy communities. Addressing these disparities is even more urgent now, given the disproportionate impact of COVID-19 on communities of color. Learn more about our digital advocacy day.
Become an AKF Ambassador
There is strength in numbers. More than 14,000 passionate patients, friends, loved ones and kidney care professionals have become AKF Ambassadors by joining our Advocacy Network. They are making a huge difference on Capitol Hill, in state legislatures and in their own communities. Together, we are fighting for policies that help patients. Become an AKF Ambassador and add your voice to the Advocacy Network by joining today.
Charitable premium assistance
In the ongoing debate over charitable premium assistance, it is easy to lose sight of the most important aspect: the patient. When AKF is unable to help low-income kidney patients to maintain their insurance coverage, the effect on patients can be devastating. Learn more about our position.
Public policy and kidney disease
Decisions made by Congress and government agencies affect the quality of care that dialysis patients receive, the amount funding for kidney disease research and the payment of health care providers. We continuously monitor regulations and legislation that affect kidney patients and their families, and—together with like-minded organizations and our Advocacy Network—we work with Congress, the administration, federal agencies, and state governments to advance our legislative and regulatory policy agenda. Read about the issues we are monitoring and working on this year.
Check out our advocacy blog to learn about best practices in engaging your elected officials, and the public policy issues affecting health care and kidney disease.
Get the latest news
Keep up with what’s going on in our Advocacy Network as well as with AKF programs and events. Read about the latest developments in legislation and policy that affect kidney patients and access to care. Catch up with the latest news.